| Literature DB >> 24141422 |
Tsuyoshi Udagawa1, Natalie G Farny, Mira Jakovcevski, Hanoch Kaphzan, Juan Marcos Alarcon, Shobha Anilkumar, Maria Ivshina, Jessica A Hurt, Kentaro Nagaoka, Vijayalaxmi C Nalavadi, Lori J Lorenz, Gary J Bassell, Schahram Akbarian, Sumantra Chattarji, Eric Klann, Joel D Richter.
Abstract
Fragile X syndrome (FXS), the most common cause of inherited mental retardation and autism, is caused by transcriptional silencing of FMR1, which encodes the translational repressor fragile X mental retardation protein (FMRP). FMRP and cytoplasmic polyadenylation element-binding protein (CPEB), an activator of translation, are present in neuronal dendrites, are predicted to bind many of the same mRNAs and may mediate a translational homeostasis that, when imbalanced, results in FXS. Consistent with this possibility, Fmr1(-/y); Cpeb1(-/-) double-knockout mice displayed amelioration of biochemical, morphological, electrophysiological and behavioral phenotypes associated with FXS. Acute depletion of CPEB1 in the hippocampus of adult Fmr1(-/y) mice rescued working memory deficits, demonstrating reversal of this FXS phenotype. Finally, we find that FMRP and CPEB1 balance translation at the level of polypeptide elongation. Our results suggest that disruption of translational homeostasis is causal for FXS and that the maintenance of this homeostasis by FMRP and CPEB1 is necessary for normal neurologic function.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24141422 PMCID: PMC3823751 DOI: 10.1038/nm.3353
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440
Figure 1Interplay between FMRP and CPEB in the brain
a, Co-immunoprecipitation of RNAs with FMRP or epitope-taqged CPEB from neurons. IgG served as a negative control. b, Acute hippocampal slices were labeled with 35S-methionine and incorporation into protein was determined by scintillation counting (n=4; ANOVA, F(3,12)=5.458, p<0.05,). * p<0.05 as compared to wild-type (student’s t-test). Error bars are S.E.M. c, DHPG-induced LTD at Schaffer collateral-CA1 synapses was enhanced in the Fmr1 KO (n=15, ANOVA, p< 0.001) and Cpeb KO (n=19, ANOVA, p< 0.001) relative to WT (n=12), however, it was nearly identical to WT in the DKO (n=14, ANOVA, p> 0.05). b, Anisomycin inhibited the DHPG-induced LTD in WT (n=13), but not in the Fmr1 KO (n=8), Cpeb KO (n=13) (ANOVA, p< 0.001), or DKO (n=16) (ANOVA, p< 0.001). DHPG-induced LTD with anisomycin in the DKO slices was significantly different from the LTD observed in Fmr1, Cpeb and WT groups. (ANOVA, p<0.001). c, Representative images of Golgi-Cox stained dendritic segments of CA1 pyramidal neurons of the hippocampus from WT, Fmr1 KO, Cpeb KO, and DKO mice. Scale bar, 20 µm. d, Total number of spines were quantified along a 60-µm segment from the origin of primary apical dendritic branches of Golgi-Cox stained CA1 pyramidal neurons. n=26 dendritic segments, ***p<0.001, *p<0.05, as compared to WT (ANOVA). #p<0.05 by two-way ANOVA (Fmr1 KO vs. DKO). Error bars are S.E.M.
Figure 2Cpeb deletion ameliorates FXS-related behavioral abnormalities
a, Audiogenic seizure in WT (n=6), Fmr1 KO (n=19), Cpeb KO (n=6), DKO (n=15), and Fmr1 KO/Cpeb heterozygous (HKO) (n=34) P19–21 mice. Seizure reduction in the DKO (40%) and HKO (44%) compared to Fmr1 KO was significant (79%, p<0.05, Fisher exact test). b, Time spent in the center of an open field for 15 min (n=9–11, ANOVA, F(4,46)=3.28, p<0.05). c, Passive avoidance memory measured by latency to enter a dark compartment 24 hours after foot shock in the dark (n=8–11, ANOVA on effect of day F(1,44)=43.5, p<0.001; on genotype F(4,44)=5.04, p<0.01). d, Nest building scored on a scale of 1–542 (left) and weight of unused nesting 24 hours after 2.5g nestlet presentation (n=9–18, ANOVA, F(4,70)=2.93, p=0.058 and F(4,70)=1.63, p=0.17, respectively) (right). e, nests after 72 hours. f, T-maze assay of spontaneous alternations (n=8–11, ANOVA on genotype F(4,44)=4.48, p<0.01). g, Hematoxylin/eosin stained hippocampus. Bar = 1mm. h, hippocampus after bilateral injection with GFP/sh-RNA-expressing lentivirus. Bar = 1mm. i, T-maze assay after bilateral hippocampal injection of Fmr1 KO mice with lentivirus expressing sh-Ctrl or sh-Cpeb (n=8–11 per treatment/genotype). j, Ribosome transit rate (RTR) in brain lysates. Quantification of radiolabel incorporation was plotted as a percentage of the maximum (40 min.). WT vs. Fmr1 KO, *p<0.05; Fmr1 KO vs. DKO, #p<0.05 (ANOVA, followed by Bonferroni’s post-hoc test, n= 3–4 per genotype; Supplementary Table 5). For all panels, * and **, p<0.05 and 0.01, respectively compared to wild-type (Mann-Whitney U test); # and ###, p< 0.05 and 0.001, respectively compared to performance on day 1 (paired t-test); + and ++ p< 0.05 and 0.01, respectively (Wilcoxon signed-rank test to test the difference from chance level of 50%). Error bars are S.E.M.